Search results
What To Know About Personalized mRNA Cancer Vaccines After Promising Trials From Moderna And Merck
Forbes· 17 hours agoCancer vaccines are finally showing promise as Moderna and Merck touted promising data on an...
Promising trial data for Moderna-Merck skin cancer vaccine sends stock rising
Quartz· 1 day agoModerna stock jumped nearly 4% on Tuesday after the the company announced positive data from an...
Moderna Investors Just Got Some Bullish News
The Motley Fool via AOL· 2 days agoWe got a taste of this during the past season, when vaccination demand was weaker than expected. So investors today aren't viewing the vaccine as a...
Is Moderna Stock a Buy Now That It's a 2-Product Company?
The Motley Fool via AOL· 2 days agoCan Moderna bounce back for investors who buy the dip? To find out, let's look at some reasons the stock fell despite the good news. Why Moderna ...
Moderna, Merck Reveal Three Year Data For Individualized Cancer Therapy In High-Risk Melanoma...
Benzinga via Yahoo Finance· 1 day agoMonday, Moderna Inc (NASDAQ:MRNA) and Merck & Co Inc (NYSE:MRK) announced the first presentation of...
FDA approves Moderna’s mRNA RSV vaccine for older adults
CNN via Yahoo News· 4 days agoThe US Food and Drug Administration has approved another vaccine that can help protect older people...
Is Moderna Stock A Buy As The U.S. Government Mulls Its Bird Flu Vaccine?
Investor's Business Daily· 4 days agoOne analyst called the results "transformational." And Moderna stock surged more than 9% on Dec. 19,...
Promising Trial Results Show New Standards In Cancer Treatment And Diagnostics Are On The Horizon
Benzinga via AOL· 3 hours agoOn Friday, Pfizer Inc (NYSE: PFE) revealed its drug for an advanced form of lung cancer showed...
Moderna, Merck say vaccine improved survival in patients with deadly skin cancer
NBC New York· 1 day agoModerna and Merck said their experimental vaccine in combination with the therapy Keytruda improved survival and showed durable efficacy in a midstage study in patients with ...
Insider Selling: Moderna, Inc. (NASDAQ:MRNA) Insider Sells 1,296 Shares of Stock
ETF DAILY NEWS· 6 days agoModerna, Inc. (NASDAQ:MRNA – Get Free Report) insider Shannon Thyme Klinger sold 1,296 shares of the company’s stock in a transaction dated Tuesday, May 28th. Following the ...
